Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Disulfiram and Copper with Chemotherapy in Metastatic Breast Cancer
NCT04265274Phase 2Withdrawn
- Sponsor
- National Cancer Institute
- Start
- Jan 2020
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of disulfiram in breast cancer, sponsored by National Cancer Institute. Planned start Jan 2020; status: withdrawn.
02
Drugs
disulfiram
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04265274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04265274.